Transplant Trends During the Covid-19 Pandemic in Mexico, Interactions Within the Healthcare Sectors.

Worldwide, healthcare systems were challenged during the COVID-19 pandemic. Tertiary hospitals, which perform the majority of organ transplants in Mexico, shifted gears to provide treatment for critically ill COVID-19 patients.
Source: Journal of the American College of Surgeons - Category: Surgery Authors: Tags: Global Surgery and Humanitarian Outreach Source Type: research

Related Links:

Conclusion: According to our study, COVID-19 infection in children with chronic lung disease has a mild course similar to that in children without chronic diseases.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Paediatric respiratory infection and immun. Source Type: research
Conclusion: Tele-coaching appears feasible in lung transplant recipients, with patients wearing the pedometer and interacting well with the app over 12 weeks. This is promising in the current climate, with the need to develop and evaluate novel ways of supporting patients remotely.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: m-Health/e-health Source Type: research
The SARS-CoV-2 virus pandemic has put a massive struggle on health care systems. The only therapeutical option at the moment is vaccination. Viral mutation may reduce the efficacy of vaccines. We analyzed if a prophylactic immune cell activation using the bacterial extract Broncho Vaxom (BV) is beneficial during a coronavirus infection. To test our hypothesis we used a mouse coronavirus (MCoV) belonging to the same virus subfamily as SARS-CoV-2. BV was applied for 10 days before MCoV challenge. Viral load was significantly reduced in BV treated animals on day 4 and 10 compared to control (qPCR and histochemistry). BV treat...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Airway cell biology and immunopathology Source Type: research
Viruses, Vol. 13, Pages 2354: Emerging Trends in the Epidemiology of COVID-19: The Croatian ‘One Health’ Perspective Viruses doi: 10.3390/v13122354 Authors: Tatjana Vilibic-Cavlek Vladimir Stevanovic Diana Brlek-Gorski Ivana Ferencak Thomas Ferenc Magdalena Ujevic-Bosnjak Irena Tabain Natasa Janev-Holcer Ivana Perkovic Mario Anticevic Barbara Bekavac Bernard Kaic Anna Mrzljak Marin Ganjto Ljiljana Zmak Maja Mauric Maljkovic Pavle Jelicic Lovro Bucic Ljubo Barbic During the four pandemic waves, a total of 560,504 cases and 10,178 deaths due to COVID-19 were reported in...
Source: Viruses - Category: Virology Authors: Tags: Review Source Type: research
DiscussionThis rapid review will assess the available evidence on whether OTr diagnosed with COVID-19 are at higher risk for severe illness and death compared to non-immunocompromised individuals. Such knowledge is clinically relevant and may impact risk stratification, allocation of organs and healthcare resources, and organ transplantation protocols during this, and future, pandemics.Systematic review registrationOpen Science Framework (OSF) registration DOI:https://doi.org/10.17605/osf.io/4n9d7.
Source: Systematic Reviews - Category: International Medicine & Public Health Source Type: research
World J Hepatol. 2021 Oct 27;13(10):1215-1233. doi: 10.4254/wjh.v13.i10.1215.ABSTRACTEmerging worldwide data have been suggesting that coronavirus disease 2019 (COVID-19) pandemic consequences are not limited to the respiratory and cardiovascular systems but encompass adverse gastrointestinal manifestations including acute liver injury as well. Severe cases of liver injury associated with higher fatality rates were observed in critically ill patients with COVID-19. Intensive care units (ICU) have been the center of disposition of severe cases of COVID-19. This review discusses the pathogenesis of acute liver injury in ICU ...
Source: World Journal of Hepatology - Category: Gastroenterology Authors: Source Type: research
World J Hepatol. 2021 Oct 27;13(10):1367-1377. doi: 10.4254/wjh.v13.i10.1367.ABSTRACTThe global pandemic of coronavirus disease 2019 (COVID-19) changed dramatically all priorities on medical society and created several challenges for clinicians caring for patients with liver diseases. We performed a comprehensive review about how COVID-19 can affect the liver, the influence of liver diseases on the risk of developing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 severity and also some strategies to overcome all the challenges clinicians have to face in the management of patients with liver disea...
Source: World Journal of Hepatology - Category: Gastroenterology Authors: Source Type: research
World J Hepatol. 2021 Oct 27;13(10):1299-1315. doi: 10.4254/wjh.v13.i10.1299.ABSTRACTThe coronavirus disease 2019 (COVID-19) pandemic has profoundly impacted liver transplant (LT) activity across the world, with notable decreases in the number of donations and procedures in most Western countries, in particular throughout the first wave. The cumulative incidence of COVID-19 in LT recipients (with estimates ranging from 0.34% to 1.56%) appears to be at least comparable to that observed for the general population. Clinical and radiological features at presentation are also similar to non-transplant patients. The risk of deat...
Source: World Journal of Hepatology - Category: Gastroenterology Authors: Source Type: research
World J Hepatol. 2021 Oct 27;13(10):1234-1268. doi: 10.4254/wjh.v13.i10.1234.ABSTRACTHepatitis C virus (HCV) is responsible for no less than 71 million people chronically infected and is one of the most frequent indications for liver transplantation worldwide. Despite direct-acting antiviral therapies fuel optimism in controlling HCV infections, there are several obstacles regarding treatment accessibility and reinfection continues to remain a possibility. Indeed, the majority of new HCV infections in developed countries occur in people who inject drugs and are more plausible to get reinfected. To achieve global epidemic c...
Source: World Journal of Hepatology - Category: Gastroenterology Authors: Source Type: research
World J Hepatol. 2021 Oct 27;13(10):1367-1377. doi: 10.4254/wjh.v13.i10.1367.ABSTRACTThe global pandemic of coronavirus disease 2019 (COVID-19) changed dramatically all priorities on medical society and created several challenges for clinicians caring for patients with liver diseases. We performed a comprehensive review about how COVID-19 can affect the liver, the influence of liver diseases on the risk of developing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 severity and also some strategies to overcome all the challenges clinicians have to face in the management of patients with liver disea...
Source: World Journal of Hepatology - Category: Gastroenterology Authors: Source Type: research
More News: COVID-19 | Hospitals | Mexico Health | Pandemics | Surgery | Transplant Surgery | Transplants